Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
EARLY_PHASE1
12 participants
INTERVENTIONAL
2015-10-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining the Feasibility and Acceptability of Good Quality Intensive CBT for OCD and Good Quality Weekly CBT for OCD
NCT02216981
iCBT for Adult Obsessive-Compulsive Disorder
NCT07081438
Personalized Computerized Inhibitory Control Training for OCD
NCT02378896
Brief Cognitive Behaviour Therapy (CBT) for Adolescent OCD in Routine Clinical Practice
NCT06983301
Targeting Taboo Thoughts In Obsessive-Compulsive Disorder
NCT04313439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Computerised CBT
Computerised CBT for OCD
Computerised CBT for OCD
Computerised CBT for OCD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computerised CBT for OCD
Computerised CBT for OCD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient describes their OCD as their main problem and scores between 14 and 30 on the YBOCS (Goodman et al, 1989). A score above 30 is in the severe range and indicates that the CBT should probably be therapist delivered.
* Able to use self-help materials in English and answer written questionnaires.
* Able to access the internet (either at home or in a public library or drop in centre or at the clinic).
* Have a current episode of OCD of more than 6 months in duration.
Exclusion Criteria
* Current active suicidal intent or severe self-neglect that requires hospitalisation.
* The patient has a primary problem of compulsive hoarding (as such patients are more complex or are more likely to be under a Community Mental Health team).
* Continuing to receive another form of psychotherapy.
* Has received CBT for OCD in the past year.
* A participant may be taking an anti-depressant for OCD but must be on a stable dose for at least 12 weeks prior to entry in the trial with no plans to alter the dose during the trial period. There must also be no plan to commence on an anti-depressant or anti-psychotic medication. (Participants excluded because of their current or planned medication may be offered a further assessment for the trial after being on a stable dose
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
South London and Maudsley NHS Foundation Trust
OTHER
Institute of Psychiatry, London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Veale
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Veale, MRCPsych
Role: PRINCIPAL_INVESTIGATOR
Institute of Psychiatry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Anxiety Disorders and Trauma
London, London, United Kingdom
South London and Maudsley NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
658-PAHTLZB
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CCBT-1111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.